FDA drug center head fired after commissioner’s exit, replaced by Davis

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A AstraZeneca slips after FDA panel rejects breast cancer drug camizestrant Hisse Senetleri 0 9
A Replimune sinks 57% on second FDA rejection of melanoma drug; stock downgraded Hisse Senetleri 0 11
A Plus Therapeutics stock gains after FDA orphan drug nod Hisse Senetleri 0 14
A Pasithea receives FDA fast track status for NF1 drug candidate Hisse Senetleri 0 18
A Corcept Therapeutics stock surges on FDA cancer drug approval Hisse Senetleri 0 8
A CRISM Therapeutics receives FDA orphan drug status for glioma drug Hisse Senetleri 0 24
A FDA clears BioVersys phase 3 trial for resistant pneumonia drug Hisse Senetleri 0 12
A US FDA warns Novo for second time about misleading drug advertising Hisse Senetleri 0 35

Benzer konular

Üst